Profil
Robert Dwyer Nolan is the founder of Cardiff Biologicals Ltd. He is currently a Non-Executive Director at Phico Therapeutics Ltd. He was previously the Chairman of Cardiff Protides Ltd. and held various Director positions at AstraZeneca PLC, Genedrive Plc, Epistem Ltd., NeuTec Pharma Ltd., and F2G Ltd. He earned a doctorate degree from King's College London.
Anciens postes connus de Robert Dwyer Nolan
| Sociétés | Poste | Fin |
|---|---|---|
| GENEDRIVE PLC | Directeur/Membre du Conseil | 31/12/2018 |
Epistem Ltd.
Epistem Ltd. BiotechnologyHealth Technology Provides biotechnology research services | Directeur/Membre du Conseil | 01/10/2008 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01/01/2004 |
Cardiff Biologicals Ltd.
Cardiff Biologicals Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development service in health sector | Fondateur | - |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Directeur/Membre du Conseil | - |
Formation de Robert Dwyer Nolan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Genedrive Plc
Genedrive Plc Medical SpecialtiesHealth Technology Manufactures and markets molecular diagnostics testing equipment | Health Technology |
Epistem Ltd.
Epistem Ltd. BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
NeuTec Pharma Ltd.
NeuTec Pharma Ltd. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Protides Ltd.
Cardiff Protides Ltd. Miscellaneous Commercial ServicesCommercial Services Operates drug design, synthesis and evaluation of leukemia and tumors | Commercial Services |
Cardiff Biologicals Ltd.
Cardiff Biologicals Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development service in health sector | Commercial Services |
Phico Therapeutics Ltd.
Phico Therapeutics Ltd. BiotechnologyHealth Technology Develops novel platform technology designed to overcome antibacterial resistance | Health Technology |
















